Walgreens results beat estimates on strong pharmacy sales, COVID-19 vaccinations

Above Article Content Ad

A Walgreens retailer is seen in Chicago, Illinois, U.S. February 11, 2021. REUTERS/Eileen T. Meslar

Oct 14 (Reuters) – Walgreens Boots Alliance Inc’s fourth-quarter outcomes beat estimates on larger U.S. and UK pharmacy retailer gross sales as a result of easing of pandemic-related restrictions and other people getting COVID-19 vaccines at its shops.

The corporate has administered greater than 40 million COVID-19 vaccines and over 16 million checks to this point, it mentioned.

Similar-store gross sales at its U.S. pharmacies rose 8.8% within the fourth quarter, which included a 485 foundation level enhance from COVID-19 vaccinations, the corporate mentioned. Walgreens stuffed 313 million prescriptions throughout the quarter.

Shares within the Deerfield, Illinois-based firm, one of many largest U.S. pharmacies, rose 1.6% to $48 premarket.

Internet earnings attributable to the corporate was $627 million, or 72 cents per share, for the quarter ended Aug. 31, in contrast with a revenue of $373 million, or 43 cents per share, a 12 months earlier.

Excluding objects, the corporate earned $1.17 per share, in contrast with Refinitiv IBES estimates of $1.02 per share.

Income rose to $34.26 billion from $30.37 billion, whereas analysts on common had estimated $33.30 billion.

Reporting by Dania Nadeem and Leroy Leo in Bengaluru; Enhancing by Vinay Dwivedi


Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button